Introduction
============

Endoscopic mucosal resection (EMR) has been shown to be safe and effective for large colorectal polyps, with the additional benefits of avoidance of surgery and cost-savings [@JR1641-1] [@JR1641-2] [@JR1641-3] [@JR1641-4] [@JR1641-5] [@JR1641-6] [@JR1641-7] [@JR1641-8] [@JR1641-9] [@JR1641-10] [@JR1641-11] . As a result, it is considered standard of care over the invasive alternative of surgical resection for benign lesions, which is supported by the recommendations of the European Society of Gastrointestinal Endoscopy (ESGE) [@JR1641-2] . However, a recent study [@JR1641-12] showed an alarming increase in rates of surgery for benign colorectal polyps in the United States between 2000 and 2014. While the cause of this is not known, one hypothesized explanation relates to perceived risk of endoscopic removal of large polyps by endoscopists without adequate training in advanced resection techniques.

EMR for large colorectal polyps is a specialized endoscopic skill that can be technically challenging [@JR1641-11] . As described in a review of colorectal EMR [@JR1641-13] , it is a "quantum leap above standard colon polypectomy" and, as such, requires dedicated training and competency assessment. Currently, EMR training and competency assessment may be obtained as one component of an advanced endoscopy fellowship in the United States; however, this approach is impractical for established gastroenterologists who are unable to dedicate a year to acquire this skill set. Although informal training for colorectal EMR such as weekend didactic and hands-on courses, educational videos, and industry-sponsored on-site preceptorships exist, there is no data on the effectiveness of these programs in ensuring EMR competency and no published data on EMR outcomes from clinicians who have trained in these types of programs. There are, at best, limited suggestions and guidance on a core EMR curriculum [@JR1641-14] . Furthermore, only a single prior study [@JR1641-15] examined the learning curve of colon EMR among three established, academic advanced endoscopists. Few studies to date have reported EMR outcomes in the West and nearly all data on rate of en-bloc resection, residual neoplasia, and adverse events (AEs) have come from experienced endoscopists.

Dedicated observational training in the time-honored, mentor-apprenticeship setting is an established model for endoscopic training in the East with published data of successful adoption amongst Western endoscopists, particularly in the setting of endoscopic submucosal dissection (ESD) [@JR1641-16] . However, there are no data on colon EMR outcomes among early-stage endoscopists.

Thus, the aim of our study was to evaluate the impact of dedicated observational training on EMR outcomes and competency in an early-stage endoscopist without advanced endoscopy training.

Patients and methods
====================

Study population and setting
----------------------------

A retrospective review was performed of an endoscopy database of patients with colorectal polyps 20 mm or larger managed by a single endoscopist (JKL) that was created in July 2014. All procedures were performed at the University of California, San Francisco (UCSF), an academic, tertiary care medical center serving over 1.2 million patients annually in the San Francisco Bay Area. The institutional review board at UCSF granted permission to review the database and the patients' corresponding electronic health records. Inclusion criteria were all consecutive adult patients 18 years of age or older who underwent a colonoscopy and EMR for a non-pedunculated (i. e., sessile or flat) polyp 20 mm or larger between July 2014 and December 2017. Polyps that appeared to have endoscopic features of invasive cancer (e. g., amorphous vessel pattern, fold convergence, etc.) were excluded from the analyses.

EMR experience and training
---------------------------

The studied endoscopist (JKL) completed a 3-year general gastroenterology fellowship at an academic institution, which included 6 months of training in advanced imaging and resection techniques at a separate institution (Palo Alto Veteran Affairs Medical Center) during the end of his general gastroenterology fellowship training. Advanced imaging and resection training consisted of knowledge acquisition through readings and videos, and direct observation of multiple EMR cases (once weekly on-site with observation of 64 cases over the six-month span) performed by two attending advanced endoscopists (RMS and TK). Advanced imaging and endoscopic resection topics that were taught through readings are summarized in **Supplemental Table 1** , which included lesion characterization, principles of electrocautery, injection fluid and technique (e. g., dynamic injection) [@JR1641-17] , resection technique, and prevention and management of adverse events (e. g., perforation, bleeding). In addition to readings, the trainee had to review videos of EMR and ESD procedures. Knowledge competency for each topic was determined during each observational session by the mentor (RMS) using the Socratic method (the use of questions and active learning to stimulate critical thinking, analysis of problems with the ultimate goal of developing a deeper understanding of the topic). Towards the end of the training program, the endoscopist performed 10 EMRs on colorectal polyps, ranging from 15 mm to 20 mm in size, at the local training institution (San Francisco Veteran Affairs Medical Center) under the direct supervision (with only verbal assistance) of an attending advanced endosocopist (YMB). No animal models were used for EMR training during the period. Upon completing gastroenterology fellowship, the endoscopist practiced independently from July 2014 and kept a log of all EMR cases along with photos for review and feedback from the two endoscopic resection experts (RMS and TK). Review and feedback of cases were done electronically and remotely through submission of photos and outcomes.

EMR procedure
-------------

After standard bowel preparation using a split-dose polyethylene glycol-electrolyte solution, colonoscopy was performed using a high-definition colonoscope (Pentax EC-3890 or EC-3490) equipped with electronic chromoendoscopy capability (i-scan) for detection and characterization of all lesions. Macroscopic appearance of all lesions was described using the Paris classification. The diameter of each lesion was estimated using an open polypectomy snare before endoscopic therapy. After lesion morphology characterization, the polyps were dynamically injected [@JR1641-17] using saline mixed with a small amount of methylene blue into the submucosal plane until sufficient lifting of the lesion was achieved. A 20-mm-diameter stiff snare (Olympus, Snaremaster) was used for en-bloc resection of the lesion (setting: EndoCut Q 3-1-3; Erbe: Marietta, Georgia, United States). If en-bloc resection was not technically possible, resection was carried out using a piecemeal technique with the 20 mm stiff snare or smaller snares (e. g., 11 mm, 13 mm, or 15 mm, Boston Scientific). In instances where small islands or bridges (\< 5 mm) of definite residual polyp were seen endoscopically despite multiple snare resection, hot forcep avulsion (setting: EndoCut Q 3-1-3; Erbe: Marietta, Georgia, United States) and/or argon plasma coagulation (APC) was applied in short bursts to treat the residual areas (20 W to 40 W, Erbe APC 300 or APC VIO, with the Erbe APC 2200 straight-fire flexible probe; Erbe Elektromedizin, Tübingen, Germany). Any immediate bleeding during the colorectal EMR procedure was treated with soft-tip coagulation (using the tip of the snare) and/or hemostatic grasper (Olympus, coagrasper hemostatic forceps). Lastly, endoscopic hemoclip(s) (Cook Medical, hemoclips) were utilized to seal the EMR defect. Resected polyps were sent for pathologic examination as part of routine clinical care and histology of polyps was evaluated by expert gastrointestinal pathologists at UCSF. A submucosal injection of Spot (GI supply Inc, Camp Hill, Pennsylvania, United States) tattoo was placed distal to the lesion to allow for localization on subsequent surveillance exams. The approach to EMR is summarized in **Supplemental Table 2** .

Post-EMR follow-up
------------------

All patients were called 24 hours and 14 days and 30 days after EMR to assess for AEs. The first follow-up colonoscopy was recommended at 6 months after EMR. All surveillance colonoscopies were performed by the same endoscopist (JKL). The EMR scar was identified endoscopically and by the presence of tattoo. During follow-up colonoscopy, any macroscopically visible neoplastic tissue was removed by either cold biopsy forceps or snare devices for histological evaluation. All EMR scars were closely inspected with high-definition imaging along with electronic chromoendoscopy. If no visible polypoid tissue was seen, the center and lateral portions of the EMR scar were biopsied using cold forceps.

Data collection and outcomes
----------------------------

Data from all patients were extracted from the electronic health records using manual chart review by a single investigator (TDK) including baseline demographic characteristics, American Society of Anesthesiologists (ASA) class, aspirin use, antithrombotic (e. g., clopidogrel, warfarin, direct oral anticoagulants) use, referral information (versus polyp identification as part of routine screening or surveillance colonoscopy), and prior endoscopic manipulation (e. g., prior forcep biopsy or prior attempt at polyp resection with snare and cautery). Procedural data such as polyp location, polyp size, Paris classification, polyp histology, en-bloc versus piecemeal EMR, EMR technique specifics, and use of prophylactic clips were also collected. Data from subsequent surveillance colonoscopies, when performed, were gathered.

Three primary outcomes were measured: 1) endoscopist assessment of complete resection defined as no residual polypoid tissue on careful observation of the EMR defect using white light and electronic chromoendoscopy; 2) AEs including perforation, post-EMR severe bleeding, and post-polypectomy syndrome; and 3) residual neoplasia at follow-up defined as the presence of macroscopically visible neoplastic tissue at the polypectomy scar or the presence of residual neoplasia on surveillance biopsies confirmed histologically. Post-EMR severe bleeding was defined as an event occurring within 30 days after EMR that required hospitalization, need for repeat endoscopy, need for a blood transfusion, or need for any other major intervention. Post-EMR severe bleeding was stratified as early (occurring within 24 hours after EMR) and delayed (occurring \> 24 hours after EMR).

Statistical analysis
--------------------

Descriptive statistics were used to characterize all patients and lesions. Continuous variables were summarized using the mean, median, standard deviation, and range; categorical variables were presented using the number and percentage. The three primary outcomes were assessed using a combination of descriptive summaries and graphical evaluation [@JR1641-15] . Specifically, EMR cases were divided chronologically into groups of 20 sequential EMRs, determined a priori based on a prior study [@JR1641-15] , and rates of the primary outcomes were calculated; these data were also represented graphically. In addition, established risk factors associated with neoplasia recurrence after EMR [@JR1641-18] such as polyp size, prior manipulation (prior biopsy, snare and/or injection), and en-bloc resection were analyzed according to sequential EMR cases. Analyses were performed using STATA 13.0 (StataCorp, College Station, Texas, United States).

Results
=======

Patient characteristics
-----------------------

Between July 1, 2014 and December 15, 2017, 145 patients were identified in the database with a large, non-pedunculated colorectal polyp ( [Fig. 1](#FI1641-1){ref-type="fig"} ). In three cases, EMR was not attempted due to concern for frank malignancy based on the endoscopic appearance -- all of these patients underwent surgical resection with histology confirming adenocarcinoma. EMR was attempted on the remaining 142 patients. [Table 1](#TB1641-1){ref-type="table"} shows the full demographic information for the 142 patients who underwent EMR.

![Flow diagram for cohort selection.](10-1055-a-1107-2711-i1641ei1){#FI1641-1}

###### Baseline patient information.

                                                           All patients (n = 142)
  -------------------------------------------------------- -------------------------------
  Mean age (years)                                          61.7 (range 26--87; SD 10.3)
  Male                                                      72 (50.7)
  Race/ethnicity                                           
  White                                                     98 (69.0)
  Hispanic                                                  19 (13.4)
  Black                                                      5 (3.5)
  Asian                                                     20 (14.1)
  ASA class                                                
  1                                                         38 (26.8)
  2                                                         71 (50.0)
  3                                                         31 (21.8)
  4                                                          2 (1.4)
  Moderate sedation                                        100 (70.4)
  Anesthesiologist administered sedation                    42 (29.6)
  Mean body mass index                                      27.6 (SD 5.6)
  Aspirin use                                               39 (27.5)
  Antithrombotic use [1](#FN1641-2){ref-type="table-fn"}    11 (7.8)

ASA, American Society of Anesthesia classification; EMR, endoscopic mucosal resection; SD, standard deviation Unless otherwise specified, values listed as number \[n, (%)\].

Clopidogrel, warfarin, direct oral anticoagulants

Mean patient age was 61.7 years (range 26--87), with a similar distribution of men and women (men, 50.7 %). While most patients were white (69.0 %), Hispanics and Asians accounted for greater than one-quarter of the patients (27.5 %). Aspirin use was common (27.5 %) and most procedures were performed with moderate sedation (70.4 %).

EMR characteristics and outcomes
--------------------------------

Among the 142 EMR cases, four were unsuccessful and these patients underwent surgical resection -- in all cases, technical failure was due to extensive scarring from previously attempted endoscopic intervention by the referring physician. The remaining 138 patients had a successful EMR. The majority of the lesions were located in the ascending colon (61.3 %) and had a flat morphology (57 %, Paris 2a, [Table 2](#TB1641-2){ref-type="table"} ). Mean lesion size was 30.4 mm (median 25 mm, range 20 mm to 100 mm). Among the 142 EMR cases, 78 cases (54.9 %) were referred for EMR, and of those referred, 64 cases had been biopsied and 10 cases had previous attempt at resection with snare and cautery.

###### EMR information.

                                 All patients (n = 142)
  ------------------------------ ------------------------
  Polyp location                 
  Cecum                           13 (9.2)
  Ascending colon                 87 (61.3)
  Hepatic flexure                  7 (4.9)
  Transverse colon                 7 (4.9)
  Splenic flexure                  1 (0.7)
  Descending colon                 4 (2.8)
  Sigmoid colon                   11 (7.8)
  Rectum                           4 (2.8)
  Ileocecal valve                  6 (4.2)
  Appendiceal orifice              2 (1.4)
  Mean polyp size (mm)            30.4 (SD 15.5)
  Median polyp size (mm)          25.0 (range 20--100)
  Paris classification           
  Is                              39 (27.5)
  Is + IIa                        18 (12.7)
  IIa                             82 (57.8)
  IIb                              1 (0.7)
  IIc                              1 (0.7)
  IIa + IIc                        1 (0.7)
  Referral for EMR                78 (54.9)
  Prior biopsy of lesion          64 (45.1)
  Prior snare of lesion           10 (7.0)
  En bloc resection               78 (54.9)
  Prophylactic clip placement    125 (88.0)
  Pathology                      
  High-grade dysplasia            13 (9.2)
  Villous adenoma                  1 (0.7)
  Tubulovillous adenoma           18 (12.7)
  Tubular adenoma                 52 (36.6)
  Sessile serrated adenoma        54 (38.0)
  Traditional serrated adenoma     2 (1.4)
  Adenocarcinoma                   2 (1.4)

EMR, endoscopic mucosal resection; SD, standard deviation

Most lesions were conventional adenomas while sessile serrated adenomas accounted for 38 % of cases; high-grade dysplasia was found in 9.2 % of cases. Of the two EMR cases in which histology showed adenocarcinoma, one patient died (cardiac event) before her scheduled surveillance and the other patient underwent successful surgical resection.

Of the 138 patients who had a successful EMR, 123 underwent surveillance colonoscopy (median time to surveillance 182 days, range 48 days to 715 days). A macroscopically visible EMR scar was identified in all surveillance colonoscopies.

EMR primary outcomes are shown in [Table 3](#TB1641-3){ref-type="table"} . There was one case of perforation (0.7 %), which did not require surgery and was managed successfully endoscopically with clip closure. All cases of early bleeding (1.4 %) were managed successfully endoscopically without the need for transfusion. Of the six cases of delayed bleeding (4.2 %), only one patient required blood transfusion and this case was also successfully managed endoscopically; the remaining were observed without need for intervention. Neither case of post-polypectomy syndrome (1.4%) required inpatient hospital admission.

###### EMR outcomes.

                                                Summary
  --------------------------------------------- ------------------
  Endoscopic assessment of complete resection   132/142 (93.0 %)
  Adverse event                                  11/142 (7.8 %)
  Perforation                                     1/142 (0.7 %)
  Early bleed                                     2/142 (1.4 %)
  Delayed bleed                                   6/142 (4.2 %)
  Post-polypectomy syndrome                       2/142 (1.4 %)
  Residual neoplasia on follow-up                 9/123 (7.3 %)

EMR, endoscopic mucosal resection

Of the nine cases (7.3 %) in which residual neoplasia were found on surveillance colonoscopy, all were of polyps that were removed initially in a piecemeal fashion and eight were of polyps in which prior resection and/or extensive biopsies were performed (two with prior attempted snare resection and six with extensive biopsies of the lesion). Additional details regarding these cases are shown in **Supplemental Table 3.** Residual neoplasia was endoscopically evident in all cases during surveillance colonoscopy with high-definition imaging along with electronic chromoendoscopy. All residual neoplasia on follow-up were small (i. e., \< 10 mm) and managed endoscopically, without surgery. Surveillance colonoscopy after endoscopic resection of residual neoplasia was performed in all nine cases with no evidence of recurrence.

EMR outcomes by increasing experience
-------------------------------------

The rate of the primary outcomes of complete resection, AEs and residual neoplasia as a function of EMR experience is displayed graphically in [Fig. 2](#FI1641-2){ref-type="fig"} . As shown, there was a decrease in the rate of complete resection between EMRs 21 to 40 (to 85 % from 100 %) with a concurrent increase in the rate of AEs (from 0 % to 15 %) and residual neoplasia (from 5.6 % to 27.8%). After 60 cases, the rate of complete resection reached and maintained its peak (at least 85 %) while rates of residual neoplasia and adverse events plateaued to 10 % or less. There were increases in factors associated with polyp recurrence such as polyp size and prior endoscopic manipulation in cases 21 to 40 as compared to 1 to 20, but these factors remained stable for subsequent cases (cases 41--142).

![EMR outcomes by increasing experience **.** \*prior manipulation includes prior biopsy, snare attempt, and/or injection.](10-1055-a-1107-2711-i1641ei2){#FI1641-2}

Discussion
==========

We showed the potential to learn colon EMR through the time-honored, mentor-apprenticeship learning method consisting of knowledge acquisition of advanced imaging and resection techniques and direct observation of EMR cases by an early-stage endoscopist, followed by proctored supervision of cases and feedback on independently performed EMRs. In our study of 142 non-pedunculated polyps ≥ 20 mm, complete endoscopic resection was achieved in 93 % of cases after this training and rates of adverse events and residual neoplasia were 7.8 % and 7.3 %, respectively. We found after 60 independent colon EMRs, rates of complete resection reached a peak and rates of AEs and residual neoplasia reached a plateau, which remained stable over the remainder of the study period.

Outcomes in this study can be compared to the single published study [@JR1641-15] of EMR learning curves for large colorectal polyps, which reported outcomes of three academic advanced endoscopists without appreciable EMR experience prior to the examined period. The study identified a threshold of 100 EMRs for large colorectal polyps to achieve rates of residual neoplasia below 20 % and complete resection above 75 %. Possible explanations for differences between the prior study and the current one include the number of endoscopists (three), varying EMR technique, type of EMR training (not specified in the previous study), and prior therapy (15 % had prior endoscopic therapy in the previous study, which is higher than the present study). Irrespective of these differences, it is clear that further data from endoscopists across different practice settings are necessary to understand the learning curve of colorectal EMR.

EMR outcomes in our study were consistent with those described in the Western literature **(Supplemental Table 4)** [@JR1641-8] [@JR1641-9] [@JR1641-15] [@JR1641-19] [@JR1641-20] [@JR1641-21] [@JR1641-22] [@JR1641-23] . These results suggest that gastroenterologists without additional formal advanced endoscopy training can acquire the necessary skill set for EMR through dedicated, comprehensive training. This rigorous training consisted of knowledge acquisition through readings and videos, direct observation of multiple EMR cases (i. e., 64 cases) performed by gastroenterologists skilled in advanced endoscopic resection techniques, and performance of EMRs by the trainee under direct supervision. In addition, remote electronic feedback was continued upon independent practice allowing for learning beyond the initial training period. The time-honored, mentor-apprenticeship model of learning endoscopic techniques through direct observational and educational training from experts has been successfully utilized for ESD in the East [@JR1641-24] and in the West [@JR1641-16] . While the specific skill set for ESD differs from EMR, the finding that specific training can lead to competency and acceptable outcomes in inexperienced endoscopists is consistent. With the rise of new forms of EMR training in the postgraduate setting through courses such as the ESGE Days hands-on training sessions, the American Society for Gastrointestinal Endoscopy Skills Training Assessment Reinforcement (STAR) certificate program, video-based learning, industry-sponsored preceptorships, and use of animal models [@JR1641-13] , there are now a variety of learning opportunities available. However, further studies are needed to determine whether any of these other models are effective and translate to acceptable clinical outcomes.

Currently, there is a paucity of data for learning curves, competency assessments, and procedural volume thresholds for colorectal EMR as compared with other advanced procedures. Learning curves for endoscopic ultrasound and ERCP, for example, have been studied in a prospective, multicenter study [@JR1641-25] and the analyses suggests that competence-based assessments (for which validated tools exist) rather than an emphasis on pure procedural volume thresholds are more indicative of technical success and mastery. Even with ESD for colorectal neoplasia, which has far fewer indications than EMR [@JR1641-26] [@JR1641-27] , there are data supporting a procedural threshold of 40 cases to minimize perforations and 80 cases to maximize en-bloc resections among endoscopists with gastric ESD experience [@JR1641-28] . Thus, it is surprising that there is little data on EMR for large colorectal polyps, given its broader applicability to gastroenterology practice. Furthermore, it is imperative that endoscopists are able to effectively perform colon EMR in the United States, given the large number of surgical resections for benign colorectal polyps [@JR1641-12] [@JR1641-26] . Ultimately, as further data on learning curves in colon EMR become available, a more sophisticated understanding of the teaching and learning process (beyond procedural volume thresholds) may lead to effective assessments of competency.

Our results should be interpreted in the context of the study's limitations. Only a single early career endoscopist was included, and as such, the results may not be generalizable. However, most studies on EMR for large colorectal polyps only report outcomes from a single endoscopist ( **Supplemental Table 4** ). Sequential cases were examined in an attempt to assess the impact of experience on the outcomes, though it is possible that unmeasured factors were associated with the outcomes such as subtle changes in endoscopic techniques. Our perspective was that these potential changes likely reflected the learning process associated with practice and experience. As all cases were carried out at an academic tertiary care center, there may be limits on generalizability; however, half the cases were not referred and found on screening or surveillance colonoscopy which strengthens the generalizability of the results in a non-referral practice. The number of pieces resected in the piecemeal EMRs was also not recorded, which may have contributed to rates of residual neoplasia. Additionally, it should be recognized that the training method in this study was an intensive and extended observational training with didactics, and feedback of cases post-observation and our findings do not obviate other training methods such as proctored hands-on experience on simulators or real patients or a combination of both. More research is needed to better understand the effectiveness of other training methods for EMR given that the practicality for gastroenterologists to observe and train from expert endoscopists for an extended period of time is likely to be limited. Lastly, we cannot exclude selection bias from incomplete follow-up data for surveillance, though having 86 % follow-up is well within the range expected based on previous studies. In any case, it is possible that the rate of residual neoplasia could be higher than identified.

Conclusion
==========

In summary, we found that an EMR skill set can be successfully acquired through comprehensive training consisting of knowledge acquisition of advanced imaging and resection techniques, direct observation of EMR cases, proctored supervision of cases, and feedback while in independent practice. This training can result in EMR outcomes similar to that reported in the Western literature. Our data suggest that by 60 colon EMR cases, the rate of residual neoplasia decreases and achieves an acceptable plateau with no effect of increasing experience on rates of complete resection and adverse events. With various EMR training opportunities available, we await more studies evaluating the effectiveness of these training methods, ultimately with the goal of developing and validating tools to improve and optimize EMR outcomes.

This work was supported by grants from the National Cancer Institute (K07CA212057) and American Gastroenterological Association, both to Dr. Lee.

**Competing interests** Dr. Lee received research funding from Pentax Medical. Pentax had no role in study design, data collection, decision to submit the manuscript for publication, and drafting of the manuscript. Dr Kaltenbach is a consultant for Olympus. Olympus had no role in study design, data collection, decision to submit the manuscript for publication, and drafting of the manuscript.

Dr. Shergill received a research gift from Pentax Medical. Pentax had no role in study design, data collection, decision to submit the manuscript for publication, and drafting of the manuscript. Dr Soetikno is a consultant for Olympus. Olympus had no role in study design, data collection, decision to submit the manuscript for publication, and drafting of the manuscript.

Drs. Lee and Kidambi: These authors contributed equally.

Supplementary material 
======================

###### 

Supplementary material

###### 

Zusatzmaterial
